WaferGen Bio-systems Inc. agreed to raise $30.4 million in a private placement of both equity and debt.
The Fremont company (OTCBB: WGBS), which makes genomic analysis technology used in biology research and drug development, made the deal with Great Point Partners LLC, Deerfield Management and Merlin Nexus, as well as with some of its board members and executives.
No comments:
Post a Comment